Bronchiolitis obliterans medical therapy

Bronchiolitis obliterans Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Bronchiolitis obliterans from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Bronchiolitis obliterans medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Bronchiolitis obliterans medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Bronchiolitis obliterans medical therapy
CDC on Bronchiolitis obliterans medical therapy
Bronchiolitis obliterans medical therapy in the news
Blogs on Bronchiolitis obliterans medical therapy
Directions to Hospitals Treating Bronchiolitis obliterans
Risk calculators and risk factors for Bronchiolitis obliterans medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Prognosis/treatment

This disease is irreversible and severe cases often require a lung transplant. Evaluation of interventions to prevent bronchiolitis obliterans relies on early detection of abnormal spirometry results or unusual decreases in repeated measurements.